XtenCHO™ transient expression system

  XtenCHO™ Race: Transforming Protein Expression with a Revolutionary Mammalian Expression System Overview of XtenCHO™ Race The XtenCHO™ Race mammalian expression system is a cutting-edge solution tailored for rapid and cost-effective recombinant protein expression. Ideal for small- to medium-scale production and high-throughput screening of drug candidates and protein variants, XtenCHO™ Race delivers unparalleled performance, drawing on 28+ years of experience in protein expression technologies. Key Features and Benefits 1. Unmatched Productivity Achieve up to 10x higher yields than competing systems.* Record-breaking results for IgG-like antibodies (1280 mg/L for Claudiximab), bispecific antibodies (>100mg/L), humanized variants (>200mg/L), and non-antibody proteins like ACE2 (>100mg/L with enzymatic activity). 2. Extended Transient Gene Expression (TGE) Sustained plasmid retention for 14+ days through efficient transfection. Enhanced plasmid stability and protein expression without additional feeding steps. 3. Shorter Protocol Shortened Protocol with harvest in only 8 days Faster production with higher yields. 4. Streamlined Workflow Simplified, step-reducing protocols to accelerate production. Backed by strong, responsive technical support. 5. Exceptional Safety and Quality Viral resistance inherent to CHO cells ensures safer production than HEK cells. Clinical-grade protein folding and human-like post-translational modifications. 6. Flexibility and Scalability Production volumes ranging from 1mL to 10L to suit diverse research needs. Biopharmaceutical-grade output at a fraction of traditional costs. 7. Global Availability Ships worldwide within 24 hours. Applications in Biopharmaceutical Development With over 3500 proteins successfully expressed, XtenCHO™ Race has demonstrated its power in advancing biopharmaceutical research. Its unparalleled yields, consistency, and cost-effectiveness make it ideal for: Early bioanalysis to detect developability issues and improve success rates in clinical trials. High-throughput testing of drug candidates and protein variants generated through mutagenesis. Production of antibodies and proteins for diagnostics, therapeutics, and structural studies. Applications in Life Science Research XtenCHO™ Race also addresses critical challenges in bioassay development across industries such as medicine, food production, and environmental analysis. By replacing hybridoma-based systems with CHO-based expression, XtenCHO™ Race enables: Superior purity, batch-to-batch consistency, and assay precision. Cost-efficient solutions for large-scale production. Seamless integration into existing workflows. Why Choose XtenCHO™ Race? CHO-based systems are the cornerstone of successful biopharmaceutical production, with nearly three-quarters of approved drugs relying on them. XtenCHO™ Race amplifies these advantages, delivering rapid and reliable results that increase your project's success potential. The kit includes: Chemically defined, animal-free expression media for optimal performance. XtenCHO™ Race Enhancer for boosted expression. Control plasmids for added flexibility and precision. Partner with XtenCHO™ Race Today XtenCHO™ Race combines innovation, efficiency, and scalability to redefine protein expression. Whether for therapeutic development or research applications, XtenCHO™ Race empowers scientists to achieve their goals with confidence and precision. *Data based on internal studies. Results may vary depending on experimental conditions.